Status
Conditions
Treatments
About
Eight hospitals in China will participate in the study, which aims to decrease the incidence of severe hyperbilirubinemia.
Full description
Through a prospective cohort study of healthy term and near-term infants, the study tries to truly reflect the epidemiology, intervention status, and outcomes of neonatal hyperbilirubinemia and the cost. Hopefully, by improving the quality of management of neonatal jaundice,we can explore and obtain a healthy term and near-term jaundice management model suitable for China's national condition, which can eventually reduce the incidence rate of neonatal severe hyperbilirubinemia and bilirubin encephalopathy.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
term or near-term neonates with gestational age ≥35w and birth weight ≥2000g.
Exclusion criteria
Infants admitted to a higher level of intervention before discharge.
Primary purpose
Allocation
Interventional model
Masking
20,000 participants in 3 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal